RAPT Therapeutics, Inc. (RAPT) Revenue History
Annual and quarterly revenue from 2017 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
Revenue Growth Metrics
RAPT Revenue Analysis (2017–2024)
As of February 28, 2026, RAPT Therapeutics, Inc. (RAPT) generated trailing twelve-month (TTM) revenue of $0. The most recent quarter (Q3 2025) recorded $0 in revenue.
Looking at the longer-term picture, RAPT's historical revenue data shows various trends over time. The company achieved its highest annual revenue of $5.0 million in 2020.
When compared to Healthcare sector peers including ARGX (+335.2% YoY), CANF (-16.0% YoY), and ABVX (+125.1% YoY). Compare RAPT vs ARGX →
Peer Comparison
Compare RAPT's revenue metrics with industry peers
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| RAPTCurrent | $0 | - | - | - | |
| ARGX | $2.2B | +335.2% | +94.6% | -1.0% | |
| CANF | $674,000 | -16.0% | -19.8% | -1206.2% | |
| ABVX | $11M | +125.1% | +457.7% | -1602.9% | |
| KYMR | $39M | -16.7% | +2.9% | -891.3% | |
| TGTX | $329M | +31.0% | +364.6% | 12.7% |
Historical Revenue Data
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $0 | - | $0 | - | $-136,101,000 | - |
| 2023 | $0 | -100.0% | $0 | - | $-127,062,000 | - |
| 2022 | $1.5M | -60.0% | $1.5M | 100.0% | $-85,795,000 | -5618.5% |
| 2021 | $3.8M | -24.4% | $3.8M | 100.0% | $-69,209,000 | -1815.1% |
| 2020 | $5.0M | - | $5.0M | 100.0% | $-53,214,000 | -1055.4% |
| 2019 | $0 | - | $-1,330,000 | - | $-43,629,000 | - |
| 2018 | $0 | - | $-1,237,000 | - | $-36,947,000 | - |
| 2017 | $0 | - | $-1,384,000 | - | $-29,331,000 | - |
See RAPT's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs RAPT Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare RAPT vs AGIO
See how RAPT stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonFrequently Asked Questions
Is RAPT's revenue growth accelerating or slowing?
RAPT TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: N/A.
What is RAPT's long-term revenue growth rate?
RAPT Therapeutics, Inc.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is RAPT's revenue distributed by segment?
RAPT reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2017-2024 are available for download. Segment mix reveals concentration and diversification trends.